drugset
Drugs / FL33-03 CAR-T
last change Jun 2026 re-read 3 minutes ago

FL33-03 CAR-T

Cell therapy

Developed for
acute myeloid leukemia
Investigated by
Beijing GoBroad Hospital · Ruijin Hospital · Shanghai Liquan Hospital · The General Hospital of Western Theater Command · Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai

Trials 1

today NCT06326021 · Ph 1
20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06326021 Apr 2024 → Jun 2026 overdue acute myeloid leukemia Beijing GoBroad Hospital Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FL-33-03 CAR-T “Optimized FL-33-03 CAR-T cells” NCT06326021 ↗
1

NCT06326021 ↗
Modality Cell therapy “Optimized FL-33-03 CAR-T cells” NCT06326021 ↗